News
Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...
AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.
DNA profiling can help stratify risk of recurrence in patients with BCG-unresponsive NMIBC treated with atezolizumab. Read ...
Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...
The most common symptom of bladder cancer is painless blood in urine. It’s more common in smokers and those exposed to ...
8d
News9Live on MSNThe future of bladder cancer care: Can latest medical advances make a difference?Bladder removal surgery is beneficial when a patient does not respond to other treatment options and when the cancer is ...
12d
News-Medical.Net on MSNUrine-based DNA test predicts bladder cancer recurrence after immunotherapyIn a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) ...
Discover a study comparing ultrasound and CBCT for bladder monitoring in prostate cancer radiotherapy to improve accuracy and ...
Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...
Beat bladder cancer with early detection! Expert insights reveal how a multidisciplinary approach can improve treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results